167 related articles for article (PubMed ID: 9642841)
21. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
[TBL] [Abstract][Full Text] [Related]
22. Oestrogens and the heart.
Rosano GM; Panina G
Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
[TBL] [Abstract][Full Text] [Related]
23. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.
Antonicelli R; Olivieri F; Morichi V; Urbani E; Mais V
Int J Cardiol; 2008 Nov; 130(2):140-6. PubMed ID: 18617278
[TBL] [Abstract][Full Text] [Related]
24. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
25. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
26. [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data].
Gaspard U
J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):340-5. PubMed ID: 18249506
[TBL] [Abstract][Full Text] [Related]
27. [Cardiovascular risk and hormone replacement therapy in menopause].
Plu-Bureau G
Therapie; 1999; 54(3):375-80. PubMed ID: 10500454
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the cardiovascular impact of hormonal replacement therapy in menopausal women].
Gaspard UJ
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):671-6. PubMed ID: 8991899
[TBL] [Abstract][Full Text] [Related]
29. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
30. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
[TBL] [Abstract][Full Text] [Related]
31. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
32. [Hormone replacement therapy in postmenopausal women and cardiovascular risk].
Karam C; Bourmayan C; Desnos M; Guérot C
Ann Cardiol Angeiol (Paris); 1995 Apr; 44(4):195-201. PubMed ID: 7632028
[TBL] [Abstract][Full Text] [Related]
33. [Menopause. Hormone substitution therapy and prevention of cardiovascular risk].
Grio R; Cellura A; Porpiglia M; Geranio R; Piacentino R
Minerva Ginecol; 1998; 50(7-8):329-31. PubMed ID: 9808958
[TBL] [Abstract][Full Text] [Related]
34. WHI risks: any relevance to menopause management?
Burger HG
Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
[TBL] [Abstract][Full Text] [Related]
35. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
Kovacev-Zavisić B; Icin T; Kovacev N
Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
[TBL] [Abstract][Full Text] [Related]
36. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.
Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
Climacteric; 2007 Dec; 10(6):508-26. PubMed ID: 18049944
[TBL] [Abstract][Full Text] [Related]
37. Sex hormones and the cardiovascular system: effects on arterial function in women.
Teede HJ
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
[TBL] [Abstract][Full Text] [Related]
38. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
Rossouw JE
Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
[TBL] [Abstract][Full Text] [Related]
39. Postmenopausal hormone therapy in clinical perspective.
Hodis HN; Mack WJ
Menopause; 2007; 14(5):944-57. PubMed ID: 17353803
[TBL] [Abstract][Full Text] [Related]
40. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
